Rollins Financial Merck & Co., Inc. Transaction History

Rollins Financial

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$102.95 - $114.33 $227,107 - $252,211	2,206 New	2,206 $227,000
Q4 2022 Feb 06, 2023	BUY	$87.44 - $112.11 $192,455 - $246,754	2,201 New	2,201 $244,000
Q2 2022 Aug 08, 2022	SELL	$83.49 - $94.64 $298,560 - $338,432	-3,576 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$73.51 - $82.4 $91,740 - $102,835	-1,248 Reduced 25.87%	3,576 $293,000
Q4 2021 Feb 01, 2022	BUY	$72.28 - $90.54 $27,538 - $34,495	381 Added 8.58%	4,824 $370,000
Q2 2021 Aug 04, 2021	BUY	$70.31 - $77.77 $312,387 - $345,532	4,443 New	4,443 $346,000

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Rollins Financial, based on Form 13F filings with the SEC.

Stay updated on Rollins Financial with notifications on news.